Recommendations on screening for chloroquine and hydroxychloroquine retinopathy: A report by the American Academy of Ophthalmology

Ophthalmology

Volumn 109, Issue 7, 2002, Pages 1377-1382

  Marmor, Michael F ^a   Carr, Ronald E ^a   Easterbrook, Michael ^a   Farjo, Ayad A ^a   Mieler, William F ^a  

^a American Academy of Ophthalmology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROQUINE; HYDROXYCHLOROQUINE;

CLINICAL FEATURE; DISEASE SEVERITY; ELECTROPHYSIOLOGY; FLUORESCENCE ANGIOGRAPHY; HUMAN; OPHTHALMOSCOPY; PRIORITY JOURNAL; RETINOPATHY; REVIEW; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; RISK FACTOR; SYMPTOM; SYSTEMIC LUPUS ERYTHEMATOSUS;

ACADEMIES AND INSTITUTES; ANTIRHEUMATIC AGENTS; CHLOROQUINE; DIAGNOSTIC TECHNIQUES, OPHTHALMOLOGICAL; HUMANS; HYDROXYCHLOROQUINE; OPHTHALMOLOGY; PRACTICE GUIDELINES; RETINA; RETINAL DISEASES; UNITED STATES;

EID: 0036288931     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0161-6420(02)01168-5     Document Type: Review

References (12)

1. Long-term course of antimalarial maculopathy after cessation of treatment
2. Hydroxychloroquine therapy in massive total doses without retinal toxicity
3. Ocular safety of hydroxychloroquine
4. Retinal toxicity in long term hydroxychloroquine treatment
5. Incidence of hydroxychloroquine retinopathy in 1,207 patients in a large multi-center outpatient practice
6. Dose refinements in long-term therapy of rheumatoid arthritis with antimalarials
7. Ocular lesions in rheumatoid arthritis and related disorders with particular reference to retinopathy
8. Chloroquine retinopathy in patients with rheumatoid arthritis
9. Chloroquine retinopathy: Is there a safe daily dose?
10. Current concepts in monitoring patients on antimalarials
11. Analysis of the ABCR (ABCA4) gene in 4-aminoquinoline retinopathy: Is retinal toxicity by chloroquine and hydroxychloroquine related to Stargardt disease?